EQUASHIELD Wins 2016 Red Dot Award for Medical Product Design

EQUASHIELD selected for elegant design innovation, increased safety and usability

31 Mar, 2016, 07:30 ET from Equashield

PORT WASHINGTON, New York, March 31, 2016 /PRNewswire/ --

Equashield, a leading provider of Closed System Transfer Devices (CSTDs) for safe and simple handling of hazardous drugs, today announced that EQUASHIELD was named a 2016 Red Dot Award winner. Participants from 57 nations submitted more than 5,000 products and innovations for the Red Dot Award: Product Design 2016. Equashield set itself apart considerably through the excellent design of EQUASHIELD, and has received the sought-after quality seal from the international Red Dot jury.

The key innovations of Equashield's CSTD, which differentiate it from its competitors, include: built-in pressure equalization system within the syringe barrel, eliminating bulky exterior air chambers; fully encapsulated syringe, preventing major spills through accidental syringe plunger removal; metal plunger rod, preventing hazardous drug contamination from the often overlooked route of exposure common to standard plastic syringes used in competing systems; dry connectors between the syringe, vials and IV bags, ensuring no drug residue escapes the system between transfers.

With 41 experts from all around the world, who are chosen according to strict rules, the Red Dot Award: Product Design guarantees a very high level of judging credibility: Only freelance designers, design professors and specialized journalists - but not designers employed at companies potentially participating - are appointed to the jury. The independent expert panel assesses each entry strictly and fairly, live and on site, according to criteria such as degree of innovation, formal quality, functionality and ecological compatibility.

"We are very proud to be recognized as a Red Dot winner this year. This acknowledgment demonstrates the superior design quality of EQUASHIELD, and shows how specific design choices can truly change the efficacy and safety of medical devices like closed systems," said Marino Kriheli, Co-Founder of Equashield. "The design innovations of EQUAHIELD made our product extremely intuitive and easy-to-use for healthcare professionals, while also providing unprecedented protection from hazardous drug exposure.

About Equashield  

Equashield is a leading provider of Closed System Transfer Devices (CSTDs), clinically proven to protect healthcare professionals from hazardous drug exposure. Incorporating a pioneering design, the company's flagship device, EQUASHIELD® II, covers more routes of exposure than alternative systems by preventing: contamination of syringe plungers, drug residuals on connector surfaces as well as exposure to drug vapor. Studies have shown Equashield's CSTD to be faster to deploy and easier to use than competing systems. The EQUASHIELD system has been cleared by the FDA under the ONB product code and substantiated in FDA-cleared labeling as preventing microbial ingress for up to seven days. 

For more information: http://www.equashield.com

Media Contact:
Finn Partners for Equashield
Glenn Jasper
goel.jasper@finnpartners.com
@goeljasper
+1-929-222-8002

SOURCE Equashield